𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Progress Towards a Needle-Free Hepatitis B Vaccine

✍ Scribed by Filipa Lebre; Gerrit Borchard; Maria Conceição Pedroso de Lima; Olga Borges

Publisher
Springer US
Year
2010
Tongue
English
Weight
769 KB
Volume
28
Category
Article
ISSN
0724-8741

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Progress towards Development of a Choler
Progress towards Development of a Cholera Subunit Vaccine
✍ Ronald K. Taylor; Thomas J. Kirn; Niranjan Bose; Emily Stonehouse; Shital A. Tri 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 618 KB

## Abstract Cholera, an enteric disease that can reach pandemic proportions, remains a world‐wide problem that is positioned to increase in incidence as changes in global climate or armed conflict spawn the conditions that enhance transmission to humans and, thus, precipitate epidemic cholera. An e

Long-term immunogenicity of preservative
Long-term immunogenicity of preservative-free hepatitis B vaccine formulations in adults
✍ Pierre Van Damme; Frank von Sonnenburg; Christoph Hatz; Bernard Hoet; Inge Lefev 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB

## Abstract Vaccination with recombinant hepatitis B vaccines is highly effective in preventing hepatitis B infection. Recently, a preservative‐free (PF) formulation of hepatitis B vaccine [GlaxoSmithKline (GSK) Biologicals, Rixensart, Belgium] has been licensed. The immunogenicity of the PF hepati

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.